Donna R. Cryer, JD

Raju Kucherlapati

Amy Miller

Brooke Ringel

Week in Review: Celebrating Patient Health

07.03.14 | By

Before we leave to celebrate the holiday weekend, we wanted to talk about the latest happenings in the biopharmaceutical industry and the importance of celebrating patients.

James Adams - Older Americans

Increasing patient care and access to medications as a way to tackle chronic disease is a vital consideration for the health of our senior generation.

I am an Officer of an organization that advocates for an increase in care with a focus on helping people at the individual level. As Americans live longer, we believe that care should focus more on the individual receiving care and not primarily on the system to which administers it.

James Adams

Rob Gundermann - Older Americans

Alzheimer’s disease, the most common form of dementia, is largely a disease of age.  The longer a person lives the more likely they are to be diagnosed with Alzheimer’s.  In fact, almost half of those over age 85 have Alzheimer’s type dementia.  As our natural lifespan increases the number of people with Alzheimer’s disease will increase as well.  Couple this with the aging of America and the baby boomer generation reaching the age where Alzheimer’s typically strikes and a looming crisis begins to emerge.

Rob Gundermann

Thair Phillips - Older Americans

We’ve all heard the statement, “50 is the new 40” or “60 is the new 50” or (any decade) is the new (previous decade minus 10). What these statements boil down to is the fact that we are healthier and living longer. New medicines, new treatments, earlier diagnosis and a healthier environment have all helped us live longer. But living longer isn’t better if our quality of life doesn’t let us enjoy those added years and the impact on the cost to the healthcare system can be enormous.


Subscribe to PhRMA RSS